Opinion|Videos|March 25, 2025
Pharmacist-Led Strategies for Adverse Event Management in mCRC
Experts discuss how pharmacists contribute to managing adverse events and toxicity for patients undergoing metastatic colorectal cancer (mCRC) treatment. They explore the factors influencing patient adherence to third-line therapies and ways pharmacists can improve patient education to enhance adherence to treatment regimens.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- In what ways do pharmacists contribute to managing adverse events and toxicity for patients undergoing mCRC treatment?
- What factors influence patient adherence to third-line therapies for mCRC, and how can pharmacists improve patient education to address these challenges and ensure better adherence to treatment regimens?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
NYC Legionnaires Disease Cluster Slows as Cooling Tower Remediation Continues
2
Female Newborns More Likely to Miss Vitamin K Prophylaxis, Hepatitis B Birth Dose
3
FDA Approved At-Home SC Lecanemab Initiation Dose for Early Alzheimer Disease
4
Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?
5